Literature DB >> 1647033

Transcriptional antagonist cAMP-responsive element modulator (CREM) down-regulates c-fos cAMP-induced expression.

N S Foulkes1, B M Laoide, F Schlotter, P Sassone-Corsi.   

Abstract

Protooncogene c-fos is induced by activation of adenylate cyclase through the major cAMP-responsive element (CRE) centered at position -60 of the promoter. cAMP induction is followed by a rapid decrease in transcriptional rate, reminiscent of down-regulation after serum stimulation. Fos protein is known to negatively autoregulate serum-induced transcription of c-fos promoter, but whether Fos is responsible for down-regulation of cAMP-induced transcription is unclear. Here we show that Fos is unable to down-regulate CRE-mediated activation. We present evidence that the transcriptional antagonist CRE modulator (CREM) can bind to c-fos CRE and heterodimerize with activator CRE-binding protein, thereby blocking cAMP induction. Furthermore, expression of antisense CREM enhances c-fos basal and cAMP-induced transcription. CREM does not antagonize serum-induced transcription; therefore, we conclude that down-regulation of c-fos is exerted by different effectors, depending upon which signal transduction pathway is activated. We speculate that, by its c-fos down-regulatory function, CREM may act as an antioncogene.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1647033      PMCID: PMC51890          DOI: 10.1073/pnas.88.12.5448

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

Review 1.  Dimers, leucine zippers and DNA-binding domains.

Authors:  S J Busch; P Sassone-Corsi
Journal:  Trends Genet       Date:  1990-02       Impact factor: 11.639

Review 2.  Cyclic AMP response element binding proteins: a cornucopia of transcription factors.

Authors:  J F Habener
Journal:  Mol Endocrinol       Date:  1990-08

3.  Regulation of transcription by cyclic AMP-dependent protein kinase.

Authors:  P L Mellon; C H Clegg; L A Correll; G S McKnight
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

4.  Inducible binding of a factor to the c-fos enhancer.

Authors:  R Prywes; R G Roeder
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

5.  Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers.

Authors:  T W Hai; F Liu; W J Coukos; M R Green
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

6.  Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB.

Authors:  K K Yamamoto; G A Gonzalez; W H Biggs; M R Montminy
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

Review 7.  Proto-oncogene fos: complex but versatile regulation.

Authors:  I M Verma; P Sassone-Corsi
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

8.  Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element.

Authors:  P Sassone-Corsi; J Visvader; L Ferland; P L Mellon; I M Verma
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

9.  The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator.

Authors:  N Webster; J R Jin; S Green; M Hollis; P Chambon
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

10.  Repression of c-fos transcription is mediated through p67SRF bound to the SRE.

Authors:  P E Shaw; S Frasch; A Nordheim
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  22 in total

1.  The coactivator dTAF(II)110/hTAF(II)135 is sufficient to recruit a polymerase complex and activate basal transcription mediated by CREB.

Authors:  E A Felinski; P G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-30       Impact factor: 11.205

2.  Distinct cAMP response element-binding protein (CREB) domains stimulate different steps in a concerted mechanism of transcription activation.

Authors:  J Kim; J Lu; P G Quinn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 3.  Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease.

Authors:  Betty S Pace; Li Liu; Biaoru Li; Levi H Makala
Journal:  Exp Biol Med (Maywood)       Date:  2015-08

4.  PhosphoCREB and CREM/ICER: positive and negative regulation of proenkephalin gene expression in the paraventricular nucleus of the hypothalamus.

Authors:  D Borsook; O Smirnova; O Behar; S Lewis; L A Kobierski
Journal:  J Mol Neurosci       Date:  1999-02       Impact factor: 3.444

5.  Regulation of γ-globin gene expression involves signaling through the p38 MAPK/CREB1 pathway.

Authors:  Valya Ramakrishnan; Betty S Pace
Journal:  Blood Cells Mol Dis       Date:  2011-04-15       Impact factor: 3.039

6.  Identification of proteins that interact with CREB during differentiation of F9 embryonal carcinoma cells.

Authors:  N Masson; H C Hurst; K A Lee
Journal:  Nucleic Acids Res       Date:  1993-06-11       Impact factor: 16.971

7.  Transcription factor CREM coordinates the timing of hepatocyte proliferation in the regenerating liver.

Authors:  G Servillo; M A Della Fazia; P Sassone-Corsi
Journal:  Genes Dev       Date:  1998-12-01       Impact factor: 11.361

8.  Overexpression of Ca2+/calmodulin-dependent protein kinase II in PC12 cells alters cell growth, morphology, and nerve growth factor-induced differentiation.

Authors:  T Massé; P T Kelly
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

9.  Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves gamma-globin activation by CREB1 and ATF-2.

Authors:  Jose Sangerman; Moo Seung Lee; Xiao Yao; Eugene Oteng; Cheng-Hui Hsiao; Wei Li; Sima Zein; Solomon F Ofori-Acquah; Betty S Pace
Journal:  Blood       Date:  2006-08-08       Impact factor: 22.113

10.  Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions.

Authors:  Joel Pekow; Urszula Dougherty; Yong Huang; Edward Gometz; Jeff Nathanson; Greg Cohen; Shawn Levy; Masha Kocherginsky; Nanda Venu; Maria Westerhoff; John Hart; Amy E Noffsinger; Stephen B Hanauer; Roger D Hurst; Alessandro Fichera; Loren J Joseph; Qiang Liu; Marc Bissonnette
Journal:  Inflamm Bowel Dis       Date:  2013-03       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.